AREV — AREV Life Sciences Global Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro Cap

Annual balance sheet for AREV Life Sciences Global, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	R2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.008	0.03	0.298	0.158	0
Net Total Accounts Receivable
Net Total Receivables	0.556	0.022	0.026	0.129	0.049
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.646	0.086	0.858	0.338	0.067
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0.794	0.419	0.284	0.186
Net Intangible Assets
Long Term Investments
Total Assets	0.646	0.879	1.28	0.623	0.253
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.712	1.41	1.87	0.716	1.21
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.712	1.41	1.92	0.716	1.21
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.065	-0.526	-0.641	-0.094	-0.953
Total Liabilities & Shareholders' Equity	0.646	0.879	1.28	0.623	0.253
Total Common Shares Outstanding